Tandem Diabetes Care
(Nasdaq:TNDM)
announced today that it launched Tandem Source, a diabetes management platform.
The platform, for both insulin pump users and healthcare providers, brings together features of Tandem Diabetes Care’s legacy offerings. It combines t:connect, t:connect HCP and t:connect Portal with new, comprehensive data reporting in one central, scalable platform.
All Tandem pump users and their providers can access Tandem Source in the U.S. The company expects international availability in 2024.
Tandem Source provides access to important therapy data and ways for users to reorder supplies and update pump software. For providers, it offers the tools necessary to seamlessly view critical patient data, identify trends and help patients manage their diabetes. Both providers and users have access to three new Tandem Source reports within the platform.
Get the full story at our sister site, Drug Delivery Business News.